FDA has approved new indicationsfor the UroLift System (NeoTract),a treatment for benign prostatichyperplasia that involves placement,via a minimally invasive procedure, ofpermanent implants that ...
The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.
Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...
UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback